Journal profile · Chemistry, Multidisciplinary
PHARMAZIE
ISSN 0031-7144 · Govi-Verlag Pharmazeutischer Verlag GmbH · GERMANY · Monthly · Founded 1946
PHARMAZIE: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.72; subscription journal; median 82 days to acceptance (37 articles, last 24 months); community-reported acceptance: about 95%; 30 articles in 2025; indexed in SCIE and Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
PHARMAZIE is published by Govi-Verlag Pharmazeutischer Verlag GmbH and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Drug Solubulity and Delivery Systems, Advanced Drug Delivery Systems and Analytical Methods in Pharmaceuticals, together about 25.9% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
The journal DiePharmazie publishs reviews, experimental studies, letters to the editor, as well as book reviews. The following fields of pharmacy are covered: Pharmaceutical and medicinal chemistry; Pharmaceutical analysis and drug control; Pharmaceutical technolgy; Biopharmacy (biopharmaceutics, pharmacokinetics, biotransformation); Experimental and clinical pharmacology; Pharmaceutical biology (pharmacognosy); Clinical pharmacy; History of pharmacy.
Source: LetPub
Research area (LetPub): Chemistry, Multidisciplinary
Main research topics OpenAlex counts of recent articles; shares are approximate
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics10.1%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics8.4%
- Analytical Methods in PharmaceuticalsChemistry7.4%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics6.5%
- Analytical Chemistry and ChromatographyChemistry6.4%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics5.3%
- Nanoparticle-Based Drug DeliveryMaterials Science4.9%
- Drug Transport and Resistance MechanismsMedicine4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Chemistry, Multidisciplinary | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Chemistry, Multidisciplinary | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Chemistry, Multidisciplinary | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
Early warning / risk: CAS Early Warning Journal List: listed in the 2023 edition (high risk) and the 2021 edition (high risk); not listed in the other 4 editions.LetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.72LetPub ·
- CiteScore 2026-06
- 1.9LetPub ·
- SJR 2026-06
- 0.23LetPub ·
- SNIP 2026-06
- 0.3LetPub ·
- h-index
- 56LetPub ·
- h-index
- 52OpenAlex ·
- i10-index
- 892OpenAlex ·
- 2-year mean citedness
- 0.55OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 29LetPub ·
Articles by year OpenAlex count · 2,513 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 37 | 37 | 5 |
| 2025 | 30 | 30 | 11 |
| 2024 | 41 | 35 | 43 |
| 2023 | 40 | 38 | 63 |
| 2022 | 65 | 63 | 189 |
| 2021 | 108 | 102 | 494 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
82 daysMedian, submission to acceptance · P25–P75 68 days – 112 days
- Acceptance to online
- —
- Submission to online
- —
- Sample
- 37 articles with submission and acceptance dates (73 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1.8 monthsLetPub ·
- Average acceptance (community reports)
- 95%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Govi-Verlag Pharmazeutischer Verlag GmbH
- Country or region
- GERMANY
- Language
- Multi-Language
- Frequency
- Monthly
- Founded
- 1946
- ISSN
- 0031-7144
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about PHARMAZIE
What CAS zone is PHARMAZIE in?
In the 2025 upgraded edition of the CAS Journal Ranking, PHARMAZIE is in Zone 4 of Medicine, and in Zone 4 of the minor category Chemistry, Medicinal / Chemistry, Multidisciplinary / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of PHARMAZIE?
The latest impact factor listed by LetPub is 0.72; CiteScore 1.9, h-index 52.
How long does peer review take at PHARMAZIE?
Based on the dates recorded on 37 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 82 days (interquartile range 68–112 days); authors report an average review time of about 1.8 months; the community-reported acceptance is “about 95%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index PHARMAZIE?
According to LetPub and DOAJ records, PHARMAZIE is indexed in SCIE and Scopus.
Is PHARMAZIE open access, and what is the APC?
PHARMAZIE is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .